|
Volumn 278, Issue 19, 2003, Pages 16926-16928
|
Levuglandinyl adducts of proteins are formed via a prostaglandin H2 synthase-dependent pathway after platelet activation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINO ACIDS;
LIPIDS;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
PHYSIOLOGICAL STIMULUS;
ENZYMES;
ARACHIDONIC ACID;
DAZOXIBEN;
INDOMETACIN;
LACTAM;
LEVUGLANDIN D2;
LEVUGLANDIN E2;
LYSINE;
PROSTAGLANDIN H2;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PYRROLE DERIVATIVE;
THROMBOXANE SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
PEPTIDE FRAGMENT;
PROSTAGLANDIN D;
PROSTAGLANDIN E;
PROSTAGLANDIN G;
PROSTAGLANDIN H;
PROTEIN;
ARACHIDONIC ACID METABOLISM;
ARTICLE;
BIOTRANSFORMATION;
BLOOD;
CHEMICAL STRUCTURE;
CONTROLLED STUDY;
HUMAN;
HUMAN CELL;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
OXYGENATION;
PRIORITY JOURNAL;
PROSTAGLANDIN METABOLISM;
THROMBOCYTE ACTIVATION;
METABOLISM;
OXIDATION REDUCTION REACTION;
ARACHIDONIC ACID;
HUMANS;
OXIDATION-REDUCTION;
PEPTIDE FRAGMENTS;
PLATELET ACTIVATION;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROSTAGLANDINS D;
PROSTAGLANDINS E;
PROSTAGLANDINS G;
PROSTAGLANDINS H;
PROTEINS;
|
EID: 0037592926
PISSN: 00219258
EISSN: None
Source Type: Journal
DOI: 10.1074/jbc.M300940200 Document Type: Article |
Times cited : (31)
|
References (15)
|